bambuterol
Sign in to saveAlso known as Bambec®, Oxeol®, terbutaline bis(dimethylcarbamate), terbutaline bisdimethylcarbamate, (+-)-5-(2-(tert-butylamino)-1-hydroxyethyl)-m-phenylene bis(dimethylcarbamate), Bambuterolum, bambutérol, (±)-5-(2-(tert-butylamino)-1-hydroxyethyl)-m-phenylene bis(dimethylcarbamate)
Bambuterol (INN) is a long-acting β adrenoceptor agonist (LABA) used in the treatment of asthma; it also is a prodrug of terbutaline. Commercially, the AstraZeneca pharmaceutical company produces and markets bambuterol as Bambec and Oxeol.
Research
197 papers- Rivastigmine-Bambuterol Hybrids as Selective Butyrylcholinesterase Inhibitors.Molecules (Basel, Switzerland) · 2023
- Clinical pharmacokinetics of bambuterol.Clinical pharmacokinetics · 1996
- Mechanism of action of bambuterol: a beta-agonist prodrug with sustained lung affinity.Agents and actions. Supplements · 1991
- [Bambuterol].Ugeskrift for laeger · 1992
- (R)-Bambuterol attenuates DSS-induced chronic colitis by suppressing inflammation, repairing intestinal barrier, and modulating gut microbiota and serum metabolomic profile.European journal of pharmacology · 2025
via PubMed
~2 min read
Encyclopedic overview
6 sectionsContents
- Indications
- Contraindications
- Adverse effects
- Interactions
- Synthesis
- References
Bambuterol (INN) is a long-acting β adrenoceptor agonist (LABA) used in the treatment of asthma; it also is a prodrug of terbutaline. Commercially, the AstraZeneca pharmaceutical company produces and markets bambuterol as Bambec and Oxeol.
It is not available in the U.S.
Excerpted from Wikipedia’s “bambuterol” article, available under the CC BY-SA 4.0 licence.
Available in 11 languages
via Wikidata sitelinks · CC0